Evidence map›Paper›PMID 8159763›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Clonal variants of hybridoma cells that switch isotype at a high frequency.

G Spira, P Gregor, H L Aguila, M D Scharff

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.Proceedings of the National Academy of Sciences of the United States of America · 1996
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

G SpiraRappaport Family Institute for the Medical Sciences, Technion, Haifa, Israel.
P Gregor
H L Aguila
M D Scharff

Funding

STRUCTURAL STUDIES OF ENOLATES FOR ORGANIC SYNTHESISK04CA001330 · NCI · BROWN UNIVERSITY · PI WILLIARD, PAUL G. · 1988 to 1992
–
SOMATIC CELL GENETICS OF IG GENESR35CA039838 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1985 to 1998
–
NCI NIH HHS CA39838NCI NIH HHS P01CA1330
6 · The paper itself

Abstract

As B cells differentiate under the influence of antigen and T cells, they frequently switch from the expression of IgM antibody to the expression of other isotypes. This is accomplished by rearranging the expressed variable region gene to downstream constant region genes and deleting the intervening sequences. Some B-cell lines that represent early stages in development switch constitutively in culture at frequencies that approach those of lipopolysaccharide- or lymphokine-stimulated normal B cells. Hybridoma cells represent a later stage of development and rarely switch in culture. In contrast to early B-cell lines, hybridomas produce large amounts of immunoglobulin, and single cells can be assayed easily for the expression of new isotypes. We have used the ELISA spot assay and fluctuation analysis to determine the rate of switching of two hybridoma cell lines. By identifying subclones that switched more frequently, we have progressively enriched for cells that switch spontaneously at higher rates. These cells, like normal cells, switch by rearrangement and deletion, and the frequency of switched cells in some of the clones is comparable to that which has been observed in less differentiated B-cell lines and in normal B cells.

Indexed as

Genes, ImmunoglobulinGenes, SwitchAnimalsClone CellsGene Rearrangement, B-Lymphocyte, Heavy ChainHybridomasImmunoglobulin GImmunoglobulin IsotypesMiceImmunoglobulin GImmunoglobulin Isotypes

Identifiers

PMID8159763
PMCPMC43589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.